Evidence map›Paper›PMID 42273675›Full record

ArticleFrontiers in immunology2026

Correction: Anti-β2GPI IgG display a broad reactivity against different β2GPI domains beyond domain 1: results from the APS ACTION and multi-center Italian cohorts.

Claudia Grossi, Caterina Bodio, Suresh Kumar, Elisa Bison, Ricard Cervera, Maria Gerosa, Michael Mahler, Diana Paredes-Ruiz, Silvia Piantoni, Massimo Radin and 14 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Claudia GrossiLaboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Caterina BodioLaboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Suresh KumarEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Elisa BisonThrombosis Research Laboratory, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Ricard CerveraDepartment of Autoimmune Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain.
Maria GerosaDipartimento di Scienze Cliniche e di Comunità, Dipartimento di Eccellenza 2023-2027, University of Milan, Milan, Italy.
Michael MahlerResearch and Development, Headquarters & Technology Center Autoimmunity, Werfen, San Diego, CA, United States.
Diana Paredes-RuizAutoimmune Diseases Research Unit, Department of Internal Medicine, Biobizkaia Health Research Institute, Hospital Universitario, Cruces, Spain.
Silvia PiantoniRheumatology and Clinical Immunology Unit, ASST Spedali Civili, Department of Clinical and Experimental Sciences, University of Brescia, ERN-Reconnect Member, Brescia, Italy.
Massimo RadinDepartment of Clinical and Biological Sciences, University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITAERN Member) with Nephrology and Dialysis Unit and Center of Immuno- Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.
Savino SciasciaDepartment of Clinical and Biological Sciences, University Center of Excellence on Nephrologic, Rheumatologic and Rare Diseases (ERK-Net, ERN-Reconnect and RITAERN Member) with Nephrology and Dialysis Unit and Center of Immuno- Rheumatology and Rare Diseases (CMID), Coordinating Center of the Interregional Network for Rare Diseases of Piedmont and Aosta Valley, San Giovanni Bosco Hub Hospital, University of Turin, Turin, Italy.
Esther Rodriguez-AlmarazHospital Universitario 12 de Octubre, Madrid, Spain.
Maria G TektonidouRheumatology Unit, First Department of Propaedeutic Internal Medicine, Joint Academic Rheumatology Program, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Angela TincaniRheumatology and Clinical Immunology Unit, ASST Spedali Civili, Department of Clinical and Experimental Sciences, University of Brescia, ERN-Reconnect Member, Brescia, Italy.
Vittorio PengoThrombosis Research Laboratory, Department of Cardio-Thoracic-Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Davide SorannaBiostatistic Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Antonella ZambonBiostatistic Unit, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Maria Laura BertolacciniAcademic Department of Vascular Surgery, School of Cardiovascular and Metabolic Medicine & Sciences, King's College, London, United Kingdom.
Hannah CohenDepartment of Haematology, University College London, London, United Kingdom.
Doruk ErkanBarbara Volcker Center for Women and Rheumatic Diseases, Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, United States.
Nicola PozziEdward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, St. Louis, MO, United States.
Francesco TedescoLaboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Maria Orietta BorghiLaboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy.
Pier Luigi MeroniLaboratory of Immuno-Rheumatology, IRCCS Istituto Auxologico Italiano, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2026.1809192.].

Indexed as

antibodiesantiphospholipid syndromediagnostic assaysdomainsβ2GPI

Identifiers

PMID42273675
PMCPMC13248120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.